Filing search / Ownership / Fresh Tracks Therapeutics, Inc. / Page 7

424B5

661r3d

12 May 22

Prospectus supplement for primary offering

4:25pm

8-K

8tfdmo4o3xygap

12 May 22

Brickell Biotech Reports First Quarter 2022

4:05pm

DEFA14A

uu4azj35lf9 z1

4 May 22

Additional proxy soliciting materials

4:09pm

DEFA14A

snwzwfe6

3 May 22

Additional proxy soliciting materials

4:22pm

8-K

lq6w1

3 May 22

Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders

4:15pm

8-K

jm050e

3 May 22

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

4:08pm

8-K

1n53g ix5m

15 Mar 22

Brickell Biotech Reports Fourth Quarter and Full Year 2021

7:33am

8-K

dgrkw

2 Feb 22

Entry into a Material Definitive Agreement

7:37am

8-K

2tinmy

14 Dec 21

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

5:13pm

8-K

o9tj9o5 q9j3

9 Nov 21

Brickell Biotech Reports Third Quarter 2021

4:07pm

8-K

3re7x

1 Nov 21

Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock

4:29pm

424B5

5xqlkqntcd2rlr8 82

28 Oct 21

Prospectus supplement for primary offering

5:20pm

424B5

h7m8cs w0

27 Oct 21

Prospectus supplement for primary offering

4:05pm

8-K

e7txdlkjk

7 Oct 21

Regulation FD Disclosure

8:30am

8-K

f0nqet vx4

7 Oct 21

Regulation FD Disclosure

6:56am